Krystal Biotech, Inc. (KRYS) has a market capitalization of $7.89B and trades at $270.00. The 52-week range is 122.8-298.303.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 38.1, Earnings Per Share (EPS) of $7.08, annual revenue of $389.13M.
The stock has a beta of 0.54, operates in the Healthcare sector.
